Search results
Krystal Biotech, Inc. (NASDAQ:KRYS): When Will It Breakeven?
Simply Wall St. via Yahoo Finance· 1 year agoKrystal Biotech, Inc. (NASDAQ:KRYS) is possibly approaching a major achievement in its business, so...
Fortress Biotech, Inc. (NASDAQ:FBIO) Looks Inexpensive But Perhaps Not Attractive Enough
Simply Wall St. via Yahoo Finance· 11 months agoFortress Biotech, Inc.'s (NASDAQ:FBIO) price-to-sales (or "P/S") ratio of 1.2x might make it look...
Fortress Biotech (NASDAQ:FBIO) investors are sitting on a loss of 81% if they invested five years...
Simply Wall St. via Yahoo Finance· 1 year agoFortress Biotech, Inc. (NASDAQ:FBIO) shareholders should be happy to see the share price up 15% in...
Cannara Biotech Inc. (CVE:LOVE) Stock's Been Sliding But Fundamentals Look Decent: Will The Market...
Simply Wall St. via Yahoo Finance· 12 months agoCannara Biotech (CVE:LOVE) has had a rough three months with its share price down 14%. However,...
Insider Buying: The Fortress Biotech, Inc. (NASDAQ:FBIO) Executive Chairman Just Bought US$70k Worth...
Simply Wall St. via Yahoo Finance· 2 years agoWhilst it may not be a huge deal, we thought it was good to see that the Fortress Biotech, Inc....
Insiders own 28% of Fortress Biotech, Inc. (NASDAQ:FBIO) shares but individual investors control 41%...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of Fortress Biotech, Inc. (NASDAQ:FBIO), it is important...
Are Investors Undervaluing Krystal Biotech, Inc. (NASDAQ:KRYS) By 41%?
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Krystal Biotech fair value estimate is...
Investors in Cannara Biotech (CVE:LOVE) have unfortunately lost 32% over the last year
Simply Wall St. via Yahoo Finance· 1 year agoInvestors can approximate the average market return by buying an index fund. Active investors aim to...
Q4 2023 Moleculin Biotech Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 month agoParticipants Jenene Thomas; Investor Relations; Moleculin Biotech Inc Walter Klemp; Chairman of the Board, President, & Chief Executive Officer; Moleculin Biotech Inc Paul Waymack; Senior Chief ...
Rakuten’s Mikitani Spends a Fifth of His Time on Biotech Startup
Bloomberg via Yahoo Finance· 9 months ago(Bloomberg) -- Hiroshi Mikitani, whose Rakuten Group Inc. is losing billions of dollars to break...
